{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:41:16Z","timestamp":1774330876839,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.parkreldis.2021.08.010","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T02:01:43Z","timestamp":1629338503000},"page":"19-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pediatric Gaucher disease with intermediate type 2\u20133 phenotype associated with parkinsonian features and levodopa responsiveness"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-5809","authenticated-orcid":false,"given":"Alejandra","family":"Darling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Ir\u00fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4746-1034","authenticated-orcid":false,"given":"Laura","family":"Gort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"D\u00edaz-Conradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7742-0589","authenticated-orcid":false,"given":"Delia","family":"Yubero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Luis","family":"De Oryaz\u00e1bal Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A\u00edda","family":"Ormaz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Artuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c0ngels","family":"Garc\u00eda-Cazorla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.08.010_bib1","series-title":"4th Edition","author":"Fernandes","year":"2006"},{"key":"10.1016\/j.parkreldis.2021.08.010_bib2","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.parkreldis.2021.08.010_bib3","first-page":"1","article-title":"The definition of neuronopathic Gaucher disease","author":"Schiffmann","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Pt 7","key":"10.1016\/j.parkreldis.2021.08.010_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2021.08.010_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-1119(90)90264-R","article-title":"Prevalent and rare mutations among Gaucher patients","volume":"96","author":"Eyal","year":"1990","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.08.010_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/adc.77.1.17","article-title":"Mutation analysis in 46 British and Irish patients with Gaucher's disease","volume":"77","author":"Hatton","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.parkreldis.2021.08.010_bib7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.parkreldis.2021.08.010_bib8","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"International Parkinson's Disease Genomics Consortium (IPDGC), Heutink P, Shulman JM. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.parkreldis.2021.08.010_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mds.27916","article-title":"Clinical evaluation of sibling pairs with Gaucher disease discordant for parkinsonism","volume":"35","author":"Lopez","year":"2020","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2021.08.010_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in \u03b1-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2021.08.010_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jmg.35.9.775","article-title":"Recurrence of the D409H mutation in Spanish Gaucher disease patients: description of a new homozygous patient and haplotype analysis","volume":"35","author":"Chabas","year":"1998","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.08.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bcmd.2001.0477","article-title":"Early-onset severe neurological involvement and D409H homozygosity in Gaucher disease: outcome of enzyme replacement therapy","volume":"28","author":"Michelakakis","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.parkreldis.2021.08.010_bib13","first-page":"674","article-title":"For the International genetics of Parkinson disease progression (IGPP) Consortium. Specifically Neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. Ann","volume":"80","author":"Liu","year":"2016","journal-title":"Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.08.010_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10545-014-9723-6","article-title":"Parkinsonism and inborn errors of metabolism","volume":"37","author":"Garc\u00eda-Cazorla","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.08.010_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: a pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2021.08.010_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejpn.2021.03.013","article-title":"Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: a long-term outcome of two siblings","volume":"32","author":"Ramad\u017ea","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:22:56Z","timestamp":1761178976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021003047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":16,"alternative-id":["S1353802021003047"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.08.010","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Gaucher disease with intermediate type 2\u20133 phenotype associated with parkinsonian features and levodopa responsiveness","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}